Provides clinical development and project management expertise in the strategy, design, and execution of pharmaceutical and medical device clinical trials.

Expanded and optimized the Research Collaboration Center of Excellence (RC COE) as a triad member responsible for ongoing development and improvement external research SOPs, process guidance training materials, the development and launch of a new electronic system platform and requirements. • Launched RC Full-Service Provider (FSP) model, successfully decreasing internal FTE costs by 50% (2023) while providing program scalability.• Served as a member of Institute of Translational & Equitable Medicine (ITEM). Lead the creation of the first ITEM RC meeting a companywide milestone on behalf of the CMO. The resulting cancer genomics initiative is the first of its kind health equity partnership between Pfizer the with the African Caribbean Cancer Consortium (AC3), as announced at the US-African Leaders Summit in the White House Cancer Moonshot report (December 2022).• Led DMTI successful pivot from neuroscience of movement disorders to using those learnings to across multiple Dermatology and Internal Medicine studies with a promising scratch/sleep algorithm program. Reduced launch times by 20% and overall business savings of 35% in comparison to internal trials. • Implemented a new consortium partnership model. Led the development and execution of first RC under the new consortium model enabling the access to and use of a novel oncology imaging biomarker to assess asset efficacy yielding an 80% cost savings in less than 2 years.• Maximized Pfizer’s clinical investment by bridging the scientific bench to the patient bedside. Ensured healthcare disparities were addressed at the time of scientific development and through physician and/or patient education as well as advocacy and community outreach for true patient impact.

Office of Interventional Cardiovascular Research and Clinical TrialsProject Management lead for:REGULATE PCI (closed)TRIAGEMACEPROMETHEUSAVIATOR 2MASCOTProject Management• Provide project management of domestic and international Phase II through Phase IV and post-marketing clinical trials. Clinical trial life-cycle responsibilities include contract and budget development, subcontracting with clinical sites and third party vendors, site selection, training of site personnel, and management of the day-to-day operational activities.• Prepare critical study documents, SOPs, work practices and clinical guidelines.• Provide oversight of clinical site performance and the documentation of all findings, outcomes, and agreements.• Establish timeline and target dates for completion of study milestones in collaboration with trial leadership by developing recruitment strategies, enrollment tracking, data analyses and manuscript preparation. Utilize data reports and site metrics to deliver milestones on time and within budget.• Track and request site and vendor payments and assist in oversight of study budget.• Prepare clinical reports of assigned projects for submission to regulatory authorities.Clinical Events Committee• Track all serious adverse events and/or reportable patient events • Review all events reported in clinical study for the identification and evaluation of safety issues and any patterns that are identifiable.• Report safety findings in a summary format to the CEC.• Prepare documentation for and attends required meetings, participates in adjudication meetings, documents results.

Responsible for clinical trial management, CRO oversight, and assisting in database management and product development.

Developed and currently conducting an fMRI study of prosody in autistic adolescents to investigate the neural correlates of prosodic speech perception in individuals with autism compared with their non-autistic siblings and unrelated control subjects.